Meiragtx Holdings Plc Stock Today
| MGTX Stock | USD 7.65 0.12 1.54% |
PerformanceOK
| Odds Of DistressLow
|
MeiraGTx Holdings is trading at 7.65 as of the 21st of March 2025; that is 1.54 percent decrease since the beginning of the trading day. The stock's open price was 7.77. MeiraGTx Holdings has only a 6 % chance of going through financial distress over the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 8th of June 2018 | Category Healthcare | Classification Health Care |
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York. MeiraGTx Holdings operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 78.85 M outstanding shares of which 2.05 M shares are now shorted by private and institutional investors with about 6.51 trading days to cover. More on MeiraGTx Holdings PLC
Moving against MeiraGTx Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
MeiraGTx Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO, Director | Alexandria Forbes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Pharmaceutical Products (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, Pharmaceutical Products, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsMeiraGTx Holdings can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand MeiraGTx Holdings' financial leverage. It provides some insight into what part of MeiraGTx Holdings' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MeiraGTx Holdings PLC (MGTX) is traded on NASDAQ Exchange in USA. It is located in 450 East 29th Street, New York, NY, United States, 10016 and employs 375 people. MeiraGTx Holdings is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 603.24 M. MeiraGTx Holdings PLC conducts business under Biotechnology sector and is part of Health Care industry. The entity has 78.85 M outstanding shares of which 2.05 M shares are now shorted by private and institutional investors with about 6.51 trading days to cover.
MeiraGTx Holdings PLC currently holds about 72.11 M in cash with (104.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.61.
Check MeiraGTx Holdings Probability Of Bankruptcy
Ownership AllocationMeiraGTx Holdings PLC maintains a total of 78.85 Million outstanding shares. Over half of MeiraGTx Holdings' outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check MeiraGTx Ownership Details
MeiraGTx Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| State Street Corp | 2024-12-31 | 602.3 K | |
| Geode Capital Management, Llc | 2024-12-31 | 570.6 K | |
| J. Goldman & Co Lp | 2024-12-31 | 550.5 K | |
| Vanguard Group Inc | 2024-12-31 | 458.9 K | |
| Dimensional Fund Advisors, Inc. | 2024-12-31 | 398.8 K | |
| Garden State Investment Advisory Services Llc | 2024-09-30 | 392.4 K | |
| Alyeska Investment Group, L.p. | 2024-12-31 | 330.2 K | |
| Northern Trust Corp | 2024-12-31 | 315.7 K | |
| Jpmorgan Chase & Co | 2024-12-31 | 306 K | |
| Perceptive Advisors Llc | 2024-12-31 | 12.6 M | |
| Sanofi | 2024-12-31 | 12.2 M |
MeiraGTx Holdings Historical Income Statement
MeiraGTx Stock Against Markets
MeiraGTx Holdings Corporate Management
| Robert MD | Chief Officer | Profile | |
| Tim Randall | Senior Controls | Profile | |
| Christine Sheehy | Senior Integration | Profile | |
| David Rubinstein | Senior Development | Profile | |
| Richard BA | COO CFO | Profile | |
| Joel Brooks | VP Fin | Profile |
Additional Tools for MeiraGTx Stock Analysis
When running MeiraGTx Holdings' price analysis, check to measure MeiraGTx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MeiraGTx Holdings is operating at the current time. Most of MeiraGTx Holdings' value examination focuses on studying past and present price action to predict the probability of MeiraGTx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MeiraGTx Holdings' price. Additionally, you may evaluate how the addition of MeiraGTx Holdings to your portfolios can decrease your overall portfolio volatility.